Consequences of hypogammaglobulinemia and steroid therapy in severe bronchopulmonary dysplasia

Pediatric Pulmonology

Volumn 22, Issue 2, 1996, Pages 96-100

  Wheeler, William ^a,b   Kurachek, Stephen ^a   McNamara, John ^a   Fugate, John ^a   Hoogenhous, Nancy ^a  

^a CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA   (United States)

^b NONE   (United States)

Author keywords

bronchopulmonary dysplasia; chronic respiratory failure of infancy; corticosteroid therapy; Hypogammaglobulinemia; intravenous gammaglobulin (IVIG); recurrent infections

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; PREDNISOLONE;

ARTICLE; CORTICOSTEROID THERAPY; HUMAN; HYPOGAMMAGLOBULINEMIA; IMMUNOMODULATION; IMMUNOTHERAPY; INFANT; INFANT DISEASE; INTRAVENOUS DRUG ADMINISTRATION; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECURRENT INFECTION; RESPIRATORY FAILURE; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; AGAMMAGLOBULINEMIA; BRONCHOPULMONARY DYSPLASIA; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; PROGNOSIS; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0029836515     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0496(199608)22:2<96::AID-PPUL3>3.0.CO;2-H     Document Type: Article

References (16)

1. O'Brodovich H, Mellins R. Bronchopulmonary dysplasia: Unresolved neonatal acute lung injury. Am Rev Respir Dis. 1985; 132: 694-709.
2. Lederman H, Metz S, Zuckerberg A, Loughlin G. Antibody deficiency complicating severe bronchopulmonary dysplasia. Pediatr Pulmonol. 1989; 7:52-54.
3. Wheeler W, Maguire E, Kurachek S, Lobas J, Fugate J, McNamara J. Chronic respiratory failure of infancy and childhood: Clinical outcomes based on underlying etiology. Pediatr Pulmonol. 1994; 17:1-5.
4. Toce S, Farrell P, Leavitt L, Samuels D, Edwards D. Clinical and radiographic scoring systems for assessing bronchopulmonary dysplasia. Am J Dis Child. 1984; 138:581-585.
5. Buckley R, Dees S, O'Fallon M. Serum immunoglobulins: Levels in normal children and in uncomplicated childhood allergy. Pediatrics. 1968; 41:600-611.
6. Kanakoudi-Tsakalidou F, Drossou-Agakidou V, Pratsidou P, Pardalos O, Andreou A. Prophylactic intravenous administration of immune globulin in preterm infants: Effect on serum immunoglobulin levels during the first year of life. J Pediatr. 1991; 119:624-629.
7. Ziment I. Corticosteroids. In: Ziment I, ed. Respiratory Pharmacology and Therapeutics. Philadelphia: WB Saunders, 1978: 232-235.
8. Vistorino RM, Hodgson HJ. Relationship between T cell subpopulations and the mitogen responsiveness and suppressor cell function of peripheral blood mononuclear cells in normal individuals. Clin Exp Immunol. 1980; 42:571-578.
9. Ballow M, Cates L, Rowe J, Goetz C, Desbonnet C. Development of the immune system in very low birth weight premature infants: Concentrations of plasma immunoglobulins and patterns of infection. Pediatr Res. 1986; 20:899-904.
10. Malik S, Giacoi G, West R. The use of immunoglobulin G (IVIG) to prevent infections in bronchopulmonary dysplasia: Report of a pilot study. J Perinatol. 1991; 3:239-244.
11. Tiller T, Buckley R. Transient hypogammaglobulinemia of infancy: Review of literature, clinical and immunologic features of 11 new cases, and long-term follow-up. J Pediatr. 1978; 92:347-353.
12. Rosen F, Cooper M, Wedgewood, R. The primary immunodeficiencies. N Engl J Med. 1984; 311:235-242; 300-309.
13. Editorial; Dexamethasone for neonatal chronic lung disease. Lancet. 1991; 338:982-983.
14. Brownlee R, Ng P, Henderson M, Smith M, Green J, Dear P. Catabolic effect of dexamethasone in the preterm baby. Arch Dis Child. 1992; 67:1-4.
15. Werner J, Sicard R, Hansen T, Solomon E, Cowett R, Oh W. Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary dysplasia. J Pediatr. 1992; 120:286-291.
16. Mukwaya G. Immunosuppressive effects and infections associated with corticosteroid therapy. Pediatr Inf Dis. 1988; 7:499-504.